Besides significantly higher circulating sLAG3 baseline values in metastatic disease (UICC stage IV, p = 0.036, Supplementary Fig. 1C), no significant differences could be seen among the different groups (Supp. The gene discussed is LAG3; the disease is metastatic neoplasm.